AI Science Tracker

Deep learning assesses heart allograft rejection from biopsy whole-slide images

Harvard Medical School; Ege University; Broad Institute of MIT and Harvard; University of California San Diego · 21 Mar 2022 · medicine

Discovery

Deep learning assesses heart allograft rejection from biopsy whole-slide images

A deep learning system analysing gigapixel endomyocardial biopsy slides detected allograft rejection with an AUC of 0.962, distinguished cellular and antibody-mediated rejection (AUCs 0.958 and 0.874) and graded rejection with an AUC of 0.833. In a human reader study it was non-inferior to conventional assessment and reduced interobserver variability and assessment time. Caveat: test cohorts from the US, Turkey and Switzerland are retrospective and the authors call for clinical trials.

Technology: Deep learning on whole-slide images for endomyocardial biopsies

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Rejection detection (AUC 0.962) was measured on a curated US dataset and independent test cohorts from Turkey and Switzerland, and a human reader study found the system non-inferior to conventional assessment.
  • Still unknown: The authors state that clinical trials are needed to establish the efficacy of AI-assisted biopsy assessment.
  • AI role: Deep learning system analysed gigapixel endomyocardial biopsy whole-slide images to detect, subtype and grade rejection.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41591-022-01709-2&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 105 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.